tirzepatide and hfpef summit trial JACC Tirzepatide for Heart Failure in

found no improvements in bone strength or microarchitecture with liraglutide, suggesting that the effects of GLP-1 receptor agonists on bone remodeling may be context-dependent and influenced by metabolic conditions

Immunomodulatory effect of protocatechuic acid on cyclophosphamide induced brain injury in rat: Modulation of inflammosomes NLRP3 and SIRT1

Many patients who are seeking treatment for obesity along with diabetes or increased cardiovascular risk will now have access to commercially available tirzepatide

Mitochondria are energy powerhouses found inside your cells

The choice of stabilizer can affect injection site comfort and peptide stability

Injectable semaglutide continues to dominate due to its established clinical efficacy, while oral formulations are rapidly gaining traction owing to improved patient convenience